The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics
Firm of the late Irving Kahn establishes position in a Berkshire bank holding Continue reading...
ViewRay, Inc. (Nasdaq: VRAY) announced today that Ludwig-Maximilians-University Hospital in Munich has begun patient treatments with MRIdian® Linac, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MRI-guidance.
ViewRay, Inc. (Nasdaq: VRAY) announced today a strategic collaboration with VieCure, an artificial intelligence (AI) informatics company with a leading point-of-care clinical decision support platform and a comprehensive electronic medical record (EMR) in oncology. The collaboration is designed to drive personalized care and treatment to patients by educating oncology practices on both companies' precision oncology solutions.
ViewRay (VRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2019. A supplemental presentation for today's conference call is included on the Company's website at http://investors.viewray.com/events/event-details/q4-2019-viewray-inc-earnings-conference-call.
VRAY earnings call for the period ending March 31, 2020.
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of B. Kristine Johnson to its Board of Directors effective April 14, 2020.
ViewRay (VRAY) delivered earnings and revenue surprises of -24.00% and -3.41%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference. Scott Drake, President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020.
The firm invests following the principles laid out by Benjamin Graham Continue reading...
Economic activities came almost to a standstill in March. However, one sector that witnessed heightening activities is health care.
ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2020 financial results.
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Q1 2020 ViewRay Inc Earnings Call
ViewRay, Inc. (Nasdaq: VRAY) announced today that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.
Q4 2019 ViewRay Inc Earnings Call
ViewRay (VRAY) delivered earnings and revenue surprises of 0.00% and 14.24%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
ViewRay, Inc. (Nasdaq: VRAY) announced today that Enloe Medical Center – an independent, nonprofit hospital in Chico, California– has entered into a master agreement for the purchase of a MRIdian MRI-guided radiation therapy system. Upon installation, Enloe Medical Center will become the first community hospital in Northern California to offer MRIdian treatments.